In theory, this could increase blood flow to the penis and help produce an erection
Human Research Limitations Human research specifically examining exogenous IGF-1 LR3 administration is remarkably limited in peer-reviewed scientific literature - searches of PubMed and other databases yield virtually no controlled clinical trials for any indication
Weight loss is rarely linear, and plateaus are common and normal during treatment
Lawitz EJ, Fraessdorf M, Neff GW, Schattenberg JM, Noureddin M, Alkhouri N, Schmid B, Andrews CP, Takcs I, Hussain SA, Fenske WK, Gane EJ, Hosseini-Tabatabaei A, Sanyal AJ, Mazo DF, Younes R
In a study conducted by Gunter et al., higher levels of IGFBP-3 in postmenopausal women were associated with a 15% reduction in the risk of CRC for every 1 ng/mL increase, with a p-value of 0.02
The lowest price of $149 per month for the lowest dose of the pill form of the drugs will be offered to consumers and Medicare and Medicaid when the drugs reach the market